Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening. A Randomized Controlled Trial. Michael Patrick Pignone et al.
When the benefits of screening programmes are mixed, how can we help patients make informed choices? A paper in JAMA Internal Medicine looks at three approaches to prostate cancer screening and how these can affect patients’ preferences. Although initially the choice of decision aid influenced preferences for screening, three quarters of each trial group subsequently opted for PSA testing – indicating that their pre-existing perspectives re screening were likely to overcome the influence of decision aids.
As with breast screening, it seems years of indoctrination are difficult to overcome.